Bacteria Genome Protein Reagent 
Drug Discovery World
JULY 18, 2023
Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases.
The Pharma Data
OCTOBER 14, 2020
The highly potent and selective payload series represents a powerful new class within ADC development with novel protein alkylating cytotoxicity. ERS Genomics – Ireland’s ERS Genomics signed an agreement with FASMAC Co., The patent is valid through 2038. Ltd of Japan. million to complete the hit-to-lead stage and up to USD 15.82
Expert insights. Personalized for you.
98 
Let's personalize your content